All Stories

  1. Cerebral Malaria and Severe Malarial Anemia, but not Other Forms of Severe Malaria, Are Associated With Long-Term Cognitive Impairment
  2. Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
  3. Elevated Levels of PDGF-BB and VEGF Are Associated With a Decreased Risk of Readmission or Death in Children With Severe Malarial Anemia
  4. Hydroxyurea reduces infections in children with sickle cell anemia in Uganda
  5. Subclinical Inflammation in Asymptomatic Schoolchildren With Plasmodium falciparum Parasitemia Correlates With Impaired Cognition
  6. sTREM-1: A Biomarker of Mortality in Severe Malaria Impacted by Acute Kidney Injury
  7. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial
  8. What Can Twins Teach Us About Malaria Epidemiology?
  9. Impact of Oxidative Stress on Risk of Death and Readmission in African Children With Severe Malaria: A Prospective Observational Study
  10. Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria
  11. Recommendations for Prevention and Control of Influenza in Children, 2021–2022
  12. The prevalence and density of asymptomatic Plasmodium falciparum infections among children and adults in three communities of western Kenya
  13. Adults Are Not Big Children: What Brain Magnetic Resonance Imaging Findings Tell Us About Differences in Pediatric and Adult Cerebral Malaria
  14. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
  15. Brain Death Secondary to Rocky Mountain Spotted Fever Encephalitis
  16. Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia
  17. Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): Study Protocol for a Randomized Placebo-Controlled Trial in Ugandan children with Sickle Cell Anemia
  18. Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): Study Protocol for a Randomized Placebo-Controlled Trial in Ugandan children with Sickle Cell Anemia
  19. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia
  20. CSF TNF in cerebral malaria and cognitive impairment
  21. Differing Causes of Lactic Acidosis and Deep Breathing in Cerebral Malaria and Severe Malarial Anemia May Explain Differences in Acidosis-Related Mortality
  22. Delaying Iron Therapy until 28 Days after Antimalarial Treatment Is Associated with Greater Iron Incorporation and Equivalent Hematologic Recovery after 56 Days in Children: A Randomized Controlled Trial
  23. Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial
  24. Timing of iron and antimalarial treatment
  25. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens
  26. Micronutrient Deficiency and Immunity
  27. Changes in Antigen-Specific Cytokine and Chemokine Responses to Plasmodium falciparum Antigens in a Highland Area of Kenya after a Prolonged Absence of Malaria Exposure
  28. Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission
  29. Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children
  30. Cerebral Malaria
  31. Pediatric Infectious Diseases
  32. Infections in Internationally Adopted Children
  33. The Association between Cognition and Academic Performance in Ugandan Children Surviving Malaria with Neurological Involvement
  34. Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens
  35. Immunomodulation inPlasmodium falciparummalaria: experiments in nature and their conflicting implications for potential therapeutic agents
  36. Correction: Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
  37. Faculty Opinions recommendation of Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children.
  38. Faculty Opinions recommendation of Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
  39. Faculty Opinions recommendation of Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
  40. Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
  41. Faculty Opinions recommendation of Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study.
  42. Antibodies to Plasmodium falciparum Erythrocyte-binding Antigen-175 are Associated With Protection From Clinical Malaria
  43. Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour
  44. Diagnosing latent tuberculosis in international adoptees remains challenging
  45. Nitric oxide for the adjunctive treatment of severe malaria: Hypothesis and rationale
  46. Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial
  47. Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
  48. Development of a Competency-Based Curriculum in Global Child Health
  49. Malaria (Plasmodium)
  50. Health Advice for Children Traveling Internationally
  51. Local topographic wetness indices predict household malaria risk better than land-use and land-cover in the western Kenya highlands
  52. Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome
  53. Adjunctive therapy for cerebral malaria and other severe forms ofPlasmodium falciparummalaria
  54. Primary Autoimmune Neutropenia Uncovered by Methicillin-Resistant Staphylococcus aureus Osteomyelitis
  55. Reply to Landman and Groeneveld
  56. Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and Hypersensitivity
  57. Possible Interruption of Malaria Transmission, Highland Kenya, 2007–2008
  58. Reliability of the Luganda version of the Child Behaviour Checklist in measuring behavioural problems after cerebral malaria
  59. Socioeconomic Predictors of Cognition in Ugandan Children: Implications for Community Interventions
  60. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals
  61. Environmental, socio‐demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a case–control study
  62. Immediate Neuropsychological and Behavioral Benefits of Computerized Cognitive Rehabilitation in Ugandan Pediatric Cerebral Malaria Survivors
  63. A Note to His Surgeon
  64. Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
  65. Malaria treatment-seeking behaviour and recovery from malaria in a highland area of Kenya
  66. Inpatient Mortality in Children With Clinically Diagnosed Malaria As Compared With Microscopically Confirmed Malaria
  67. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease
  68. Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands
  69. Antibodies to Pre‐erythrocytic Plasmodium falciparum Antigens and Risk of Clinical Malaria in Kenyan Children
  70. Cerebral Malaria Pathogenesis
  71. Low Levels of RANTES Are Associated with Mortality in Children with Cerebral Malaria
  72. Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations
  73. Therapies and Vaccines for Emerging Bacterial Infections: Learning from Methicillin-resistant Staphylococcus aureus
  74. Antibodies to Plasmodium falciparum Antigens Vary by Age and Antigen in Children in a Malaria-Holoendemic Area of Kenya
  75. Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997
  76. Drug treatment of malaria in children
  77. The revolution in molecular biology leads to new understanding of the clinical expression of immunodeficiencies
  78. Recurrent fever in children
  79. Community-Acquired, Non-Antibiotic-Associated Clostridium difficile Colitis in a Child
  80. About your child
  81. SUCCESSFUL MEROPENEM TREATMENT OF MULTIPLY RESISTANT PNEUMOCOCCAL MENINGITIS
  82. Flogging Trolls